Tuesday, February 13, 2007

This blog now in 'holding mode'

This blog is going into 'holding mode', and will not be updated as from today.

The reason is that The ME Association's news blog has moved to our newly designed website which went live this morning on www.meassociation.org.uk

For regular news updates from The MEA and the ME world in general, and a host of other features and information, please click on the following link

MEA website

Monday, February 12, 2007

Genes study resumes today

A vital ME Association-funded study into the genetic origins of ME/CFS enters a new phase today (Monday, February 12) – when a full-time research assistant joins the team at Glasgow Caledonian University.

The study – a world-leader in that it is exploring the whole human genome of 33,000 genes, compared with smaller studies elsewhere – was set up originally two years ago by Dr John Gow at Glasgow University. It was then delayed when it proved impossible to find funding for more than a small-scale first stage.

But then Dr Gow moved to Glasgow Caledonian University as their director for forensic investigation, was awarded a full professorship and given permission to recruit a full-time researcher to the ME/CFS project.

The arrival of the new research assistant, Dr Gillian Gibson PhD, means that Professor Gow can pick up the reins again – as of today.

"This is good news for cutting-edge research into how the vast number of genes in the body behave in people with ME/CFS", said Dr Charles Shepherd, medical adviser to The ME Association.

"We know from the work that John has done so far that significant abnormalities in some genes appear to be uniquely expressed in people with ME/CFS. He can now forge ahead to test the science involved through the recruitment of a wider spread of research volunteers."

The study is being funded by The ME Association's Ramsay Research Fund, which is wholly dedicated to promoting research into the physical nature and causes of the illness.

In the phase starting this week, Dr Gow will be recruiting healthy volunteers as control samples, as well as patients suffering from other disorders such as depression where fatigue can be a major clinical feature. Clinicians who will be providing the research volunteers are now being alerted to the resumption of work.

Dr Shepherd commented: "There is as yet no reliable diagnostic test for ME/CFS, and no proven cure. The ultimate aims of this study are to identify specific genetic markers that can be used as a diagnostic test and to assess new forms of treatment specifically aimed at correcting the genetic abnormalities involved in ME.”

ENDS

Friday, February 09, 2007

What is an encephalopathy?

MAY BE REPOSTED

The decision by researchers on the American CFS Name Change Advisory Board (meeting in Florida on 12 January 2007) to agree that a new name should be adopted for chronic fatigue syndrome (CFS) is obviously very welcome. At the same time they have expressed support for the use of the term ME, as myalgic encephalopathy (as this is 'diagnostically accurate') rather than myalgic encephalomyelitis.

This decision has once again opened up the debate over what is the most appropriate term to use to describe the clinical, examination and pathological features of this illness.

The reason why so many clinicians and researchers now either refuse, or are extremely reluctant to use the term ME – as myalgic encephalomyelitis – is due to the continuing lack of evidence to demonstrate that the principal pathological feature is a widespread inflammatory change taking place within the brain (ie encephalitis) and the spinal cord (ie myelitis). And while there is undoubtedly some evidence of past or present inflammatory changes within the central nervous system taking place in some people with ME/CFS (mainly in research defined CFS cases) this is not the sort of evidence that would confirm a diagnosis of encephalomyelitis to a neurologist.

Evidence of past or present inflammation within the CNS can have a number of explanations and care needs to be taken to avoid drawing conclusions from existing research material (the results of neuroimaging studies in people with research defined CFS in particular) that cannot be justified on scientific grounds. Adopting this approach is also likely to be counter-productive when it comes to challenging medical opinion on the issue of nomenclature.

Consequently, some doctors, including myself, have proposed that the term encephalopathy should replace encephalomyelitis (as the E in ME) on the grounds that encephalopathy is a far more appropriate description of the neurological symptoms, signs and investigative abnormalities that have been described in the literature.

Encephalopathy is also a term that doctors cannot simply dismiss on the grounds that it is pathologically inaccurate in relation to ME (or research defined cases of CFS).

There does, however, continue to be considerable confusion over what an encephalopathy is with some people claiming, quite wrongly, that it is a psychiatric diagnosis rather than a medical diagnosis.

To provide some clarification, the key features of an encephalopathy (all of which are consistent with ME/research defined CFS) are listed below:

1 A significant and sometimes diffuse disorder of the brain that can involve both changes to structure and function.

2 A neurological disorder than can be caused by infections (viral, bacterial, prion), metabolic or mitochondrial dysfunction, exposure to toxins (eg drugs, chemicals, pesticides), lack of oxygen or blood supply to the brain.

3 A disorder that commonly produces serious disturbances in cognitive function - involving memory, concentration etc.

4 Other neurological symptoms that can be found in an encephalopathy include myoclonus (twitching of muscles or muscle groups), nystagmus (involuntary eye movements), tremor, muscle atrophy and weakness, dysequilibrium (and unsteady gait), paraesthesiae (sensory disturbances) , hypothalamic dysfunction, orthostatic intolerance and postural hypotension.

5 More serious neurological symptoms, as described in section 4.2.1.2 of the Chief Medical Officer's report (eg seizures), can also be found in encephalopathies.

6 Mood disturbances can occur.

7 Abnormalities can be found on neuroimaging, spinal fluid examination and electroencephalogra ms - depending on the cause of the encephalopathy.

Examples of well recognised neurological encephalopathies include:

Bovine spongiform encephalopathy ('mad cow disease')

Coxsackie virus encephalopathy

HIV encephalopathy (and AIDS dementia complex)

Hepatitis C encephalopathy

Liver (cirrhotic) encephalopathy

Lyme disease encephalopathy

Mycoplasma encephalopathy

Sarcoid encephalopathy

Wernicke's (thiamine deficiency) encephalopathy

This is an important debate and I am pleased that it is now taking place in America as well as here in the UK.

Dr Charles Shepherd (UK)
[Posted in a personal capacity]

Wednesday, February 07, 2007

Gibson Report: key points raised by The ME Association

MAY BE REPOSTED

Below is a summary of key points raised by The ME Association during the meeting at the House of Commons on Tuesday 6 February to discuss feedback to the Gibson Inquiry Report.

A detailed summary of the meeting is being prepared for the March issue of ME Essential magazine.

Dr Charles Shepherd
Medical Adviser, The ME Association
---------------------------------------------------------------------------------------------
1 THE MEA RESPONSE

The ME Association has already made it clear in our public statement that we welcome many of the key recommendations and conclusions in the report.

We have set up an archive blog for all the presentations to the five oral hearings (http://meagibsoninq uiry.blogspot. com) and a feedback blog (http://gibsonfeedba ck.blogspot. com) where anyone can post comments on the report. The feedback blog was set up following a request from Dr Richard Taylor MP for the MEA to act as a central collecting point for public comment. We hope that members of the Inquiry group will take time to read the comments that have been posted on the feedback blog.

We are also very keen to continue to co-operate with the Gibson Inquiry team regarding future initiatives, in particular the proposed Early Day Motion (EDM).

2 CONCERNS ABOUT SPECIFIC SECTIONS IN THE REPORT

We share some of the concerns that have been expressed by our members about a number of either unhelpful or inaccurate statements in certain key areas of the report.

In particular:

SECTION 2.4 ME IN TEENAGERS AND CHILDREN

This section should have included specific reference to the important information given by Dr Nigel Speight in his presentation to the fourth oral hearing. The sentence containing the statement ....possibly in children is going to be interpreted as indicating that a diagnosis of ME/CFS is unlikely in children. It should therefore be rewritten.

SECTIONS 3.1 THE ORAL HEARINGS & 3.2 OTHER EVIDENCE WE RECEIVED

This should include a complete list of speakers (possibly as an appendix) from all five oral hearings

In relation to the evidence presented by Dr Byron Hyde (3.2) on neuroimaging studies (ie MRI, PET and SPECT scans), it is incorrect for the report to say that Again, others have yet to confirm or refute these observations. The results of a considerable number of published papers relating to abnormal findings using neuroimaging techniques add considerable weight to the classification by WHO of ME (and CFS) as a neurological disorder in G93:3 of ICD 10. Further evidence of neuroimaging abnormalities, including references to published papers, was presented to the first oral hearing by the MEA. A transcript of this presentation is available on the official Gibson Inquiry website: http://erythos. com/gibsonenquir y/PresDocs. html

SECTION 3.3.4 VACCINATION

We know of no evidence to support the claim that Vaccination is often blamed for unexplained outbreaks of illness and regularly appears in the media being accused of such. The evidence for vaccines acting as a trigger factor in ME/CFS is both theoretical (as the CMO report acknowledged) and anecdotal - with at least four physicians who presented evidence to the oral hearings (ie Drs Hyde, Shepherd, Weir and Professor Pinching) having experience of cases where vaccines have been involved - hepatitis B in particular. The statement that The Group found that there is no strong evidence to link CFS/ME to vaccination and it is unlikely to be the cause is therefore most unhelpful and will no doubt be used to deny industrial injury benefits to people with vaccine precipitated ME/CFS who may well have a good case to make.

SECTION 4.2 EXISTING TREATMENTS

It is incorrect to include pacing (in 4.5) as the third of the three psychosocial therapies.

SECTION 6.0 BENEFIT ENTITLEMENT

It is incorrect to state in 6.1 in reference to the Disability Living Allowance that: Therefore claimants are not entitled to the higher level of benefit payments. People with ME/CFS do have great difficulty in claiming higher rate care and/or mobility component of DLA (as acknowledged in the ministerial reply from Maria Eagle quoted in 6.2) but there has been no statement from the DWP to indicate that higher rate claims cannot be made. A number of people with ME/CFS do, in fact, successfully claim higher rates of DLA. Unfortunately, this inaccuracy has now been repeated in the press (ie You magazine, Mail on Sunday, January 21) and this may well result in people with severe ME/CFS not submitting a claim for higher rate DLA because they assume they cannot do so.

Whilst appreciating that the report was finalised in very difficult circumstances in order to meet the deadline for submissions to the NICE guideline development process, we believe that these sections must be looked at again and some form of clarification or correction made.

3 HOW CAN THE REPORT BE USED TO CHALLENGE DAMAGING NEW GUIDANCE FROM THE DWP, NICE AND NHS PLUS?

Consideration now needs to be given as to how the key message in this report - ie that the past and current clinical and research emphasis on psychological and social factors in causation and management has been highly detrimental to patients - must be taken forward, especially in relation to unacceptable guidance on the illness that:

a.. has already been issued by NHS Plus in relation to employment
b.. is about to be issued by the DWP in relation to disability benefits
c.. is being proposed by NICE in relation to clinical assessment and management
NB Joint responses from the main ME/CFS support organisations have already been sent to the DWP and NICE. The MEA is currently co-ordinating a joint response to the NHS Plus guidance.

The ME Association
6 February 2007

Tuesday, February 06, 2007

Minister makes it a musical 50th for ME


Instead of having a traditional 50th birthday for family and friends, the minister of the United Reformed Church in the Scottish fishing port of Fraserburgh will be having a musical celebration instead.

The Rev Stephen Brown will be pulling all the stops out on Saturday, February 24, for "The Minister and his Music – a Celebration for ME". This will be a concert inside the church, with the admission ticket being one of the MEA's marbled purple and white wristbands.

One hundred wristbands have already been handed out, and there's space inside the building for another 120 concertgoers. The event will begin at 7.30pm. Mr Brown plays a variety of instruments, and will be joined on stage by other musicians.

The minister's wife, Jan, who has ME, said today: "Stephen's part of a group and plays a variety of instruments himself. If the concert goes well, he may even take it on tour!"

Picture: "I will make you fishers of men"... Fraserburgh URC's stained glass window, which was dedicated in October 2003.

Health Select Committee to investigate NICE

Health Committee Press Notice, 2 February 2007

National Institute for Health and Clinical Excellence (NICE)

The Committee has decided to undertake an inquiry into aspects of the work of the National Institute for Health and Clinical Excellence. Areas of particular interest include:

• why NICE’s decisions are increasingly being challenged;

• whether public confidence in the Institute is waning, and if so why;

• NICE’s evaluation process, and whether any particular groups are disadvantaged by the process;

• the speed of publishing guidance;

• the appeal system;

• comparison with the work of the Scottish Intercollegiate Guidelines Network (SIGN); and

• the implementation of NICE guidance, both technology appraisals and clinical guidelines (which guidance is acted on, which is not and the reasons for this).


Written evidence should if possible be in Word or rich text format—not PDF format—and sent by e-mail to healthcommem@parliament.uk. The body of the e-mail must include a contact name, telephone number and postal address.

The e-mail should also make clear who the submission is from.

The deadline is Friday 23 March 2007.

Submissions must address the terms of reference. They should be in the format of a self-contained memorandum and should be no more than 3,000 words. Paragraphs should be numbered for ease of reference, and the document must include an executive summary. Further guidance on the submission of evidence can be found at www.parliament.uk/documents/upload/witnessguide.pdf . Submissions should be original work, not previously published or circulated elsewhere, though previously published work can be referred to in a submission and submitted as supplementary material. Once submitted, your submission becomes the property of the Committee and no public use should be made of it unless you have first obtained permission from the Clerk of the Committee. Please bear in mind that Committees are not able to investigate individual cases.

The Committee normally, though not always, chooses to publish the written evidence it receives, either by printing the evidence, publishing it on the internet or making it publicly available through the Parliamentary Archives. If there is any information you believe to be sensitive you should highlight it and explain what harm you believe would result from its disclosure; the Committee will take this into account in deciding whether to publish or further disclose the evidence.

For data protection purposes, it would be helpful if individuals wishing to submit written evidence send their contact details in a covering letter or e-mail.

Evidence sessions are likely to commence after the Easter recess and a later press notice will give details of these.

The Health Committee is a Select Committee of the House of Commons. It is appointed under Standing Order No.152 to examine the expenditure, administration and policy of the Department of Health and associated public bodies. The Committee has the power to send for persons, papers and records.

Saturday, February 03, 2007

Diary dates from The ME Association

Here is a list of this year's ME/CFS events notified to us so far. If you would like your event to be flagged up on this website, or included in our quarterly magazine ME Essential, please click on the email link at the end of this item.

All we ask is that the event should have an ME/CFS focus, and be of interest to people outside your immediate group – for example, a conference, meeting or other event intended to attract visitors rather than a social gathering for members only.

Note: please always check with the organisers before travelling that the event is still going ahead.

February 15-16, Claridge House, Lingfield, SURREY
Gentle Yoga to boost health and stamina, with Tim Frances, Details, tel: 01342 82150.

Saturday, 17 February, Littlebury Hotel, Kings End, BICESTER, Oxfordshire
AGM and EGM of The ME Association, 2pm. Members only event. Details: Gill Briody, tel: 01280 818964/


Saturday, 17 February, R M Sports Club, Newark Road, LINCOLN
Professor Tony Pinching speaks to Lincolnshire ME Self-Help Group, 2pm. Details: Peter Talbot, tel: 01522 871295

Friday, 23 February, Redmond Centre, High Street, Carcroft, Doncaster DN6 8DP.
Meeting on 'ME/CFS Employment Matters' organised by Doncaster, Barnsley and Dearne Valley Leger-ME Support Group, 1.30m. Opportunities for confidential discussion after talk with main speaker. Speaker: Ken Hill, employment support worker with South Yorkshire Centre for Independent Living. Details: Mike Valentine, tel: 01302 7873353, email Mike

Saturday, 24 February, United Reformed Church, FRASERBURGH
"The Minister and his Music – a Celebration for ME", 7.30pm. concert by the Rev Stephen Brown, admission by MEA wristband, available from the minister. Tel: 01346 517811.

Monday, 26 February, Millenium Hall, Roffey, near Horsham, Sussex
Meeting organised by Sussex and Kent ME/CFS Society and Fibromylagia Support Group for Surrey and Sussex, 11am. A patient group representative from Israel will be sharing her experience of the illnesses and talking about the protocol often used in her country to improve patients' quality of life. A DVD by British doctor, Michael Midgley, 'Miracles,Medicine and ME: A practical guide to living with ME/CFS and Fibromyalgia' will also be shown.
Further information from Jo Fisher on 01403 255450

Saturday, 3 March, Kidlington Community Education Centre, OXFORD
Lecture by Mary Black, occupational therapist with the PACE Trial “Occupational Therapy and CFS/ME”, 2.30pm Lecture organised by Oxfordshire ME Group for Action (OMEGA).

Thursday, 8 March, Community House, 311 Fore Street, Edmonton, LONDON N9 0PZ,
Alex Howard speaks on ‘Freedom from ME – the very latest research and what it means to you’, 7.30pm. Event organised by Network ME, North London, phone Mirna Peach on 0208 373 6260 to book place.

Saturday March 17, Sheldrake Suite, Martlets Hall, Burgess Hill, WEST SUSSEX RH15 9NN
Children and Young People with ME, conference organised by reMEmber with the Association of Young People with ME. 2pm Speakers: Dr Kamel Patel, consultant paediatrician at the Royal Alexandra Hospital in Brighton, and Mary-Jane Willows, chief executive of AYME. Tickets £5 (adults), under-16s admitted free but entry by ticket only. Tel: 01273 831733.

March 26-30, Claridge House, Lingfield, SURREY
ME retreat with Nomi Sharron. Details, tel: 01342 82150.

Thursday, 29 March, Community House, 311 Fore Street, Edmonton, LONDON N9 0PZ,
Workshop led by Chandrika Wimalratne. “You can heal your life’. 7.30pm. Topics: creative visualisations, mirror work, positive thinking. Entrance fee: £5 per person. Please bring small mirror. Event organised by Network ME, North London, phone Mirna Peach on 0208 373 6260 to book place.

March 27-31, Carberry Tower, Musselburgh, near EDINBURGH
Five-day caring break for people with ME. For details, tel: 0131 665 3135 or email mail@carberrytower.com

Saturday, March 31, Lammermuir Hall, St Cuthbert’s Church, 5 Lothian Road, EDINBURGH
Talk by Dr Charles Shepherd: “ME/CFS: All that’s new in research and management plus a few hot topics – Benefits, Gibson and NICE”, 2pm (doors open at 1.30pm). Admission free. Wheelchair access. Refreshments. More details from Edinburgh ME Self-Help Group, www.edmesh.org.uk or Jo Bluett, tel: 0131 228 5589.

April 10-20, Claridge House, Lingfield, SURREY
ME retreat, with Nomi Sharron. Details, tel: 01342 82150

Saturday, April 14, Northern Ireland ME Association Conference
Full day meeting: Speakers include Professor John Gow and Drs Jonathan Kerr, Charles Shepherd and William Weir. Further information from NI MEA, tel: 028 9024 3082, website www.nimea.org

May 2-3, WESTMINSTER
Invest in ME 2nd International Conference. For details, email info@investinme.org or visit www.investinme.org

Friday May 4, Connah’s Quay Civic Hall, Wepre Drive, Connah’s Quay, Flintshire, NORTH WALES
Afternoon conference organised by Clwyd ME Support Group, Main speaker: Dr Charles Shepherd, medical adviser to The ME Association, and possibly one other.
Tel: 01244 819315

May 7-11, Ammerdown Centre, near BATH
‘Time to be ME’, a five-day holiday for people with ME. £297 (all-inclusive). Bursaries may be available for people on benefits or low income. Tel: 01761 433 709, or visit www.ammerdown.org

Thursday, May 10, CENTRAL LONDON
ME ‘People’s Day’ Event for ME Awareness Week. from 11am. Demonstration, presentations to 10 Downing Street, lobby of Parliament. For further information, email M.E.PeoplesEvents2007@hotmail.com

Saturday, 12 May – ME Awareness Day, Brentwood Cathedral, ESSEX
‘Remember the Children’, an evening of music and poetry to raise awareness of ME in children, supporting the work of the Young ME Sufferers Trust, 8pm. Ticket prices: £9.50, concessions £6.50. Advance bookings guarantee seats in the reserved area. Tel: 01245 401080 or via www.tymestrust.org

Wednesday May 16, Lord Hill Hotel, SHREWSBURY
Annual Conference organised by Shropshire and Wrekin ME Support Group, Regency Suite, Lord Hill Hotel, Abbey Foregate, Shrewsbury, 7-9pm. Speaker: Professor Malcolm Hooper, Emeritus Professor of Medicinal Chemistry, University of Sunderland.
Details: 01743 235638. Entry free, but donation welcome towards S&WMES funds.

Friday May 25, Edinburgh Conference Centre, Heriot-Watt University, EDINBURGH
ME Research UK ‘New Horizons’ biomedical research conference, co-sponsored by the Irish ME Trust. For details, tel: 01738 451234, email
meruk@pkavs.org.uk or visit www.meresearch.org.uk

Saturday, June 2, ABERDEEN
Aberdeen and North East of Scotland ME/CFS Self Help Group meeting, 2pm. Speaker: Dr Charles Shepherd, medical adviser to The ME Association
For details. tel: 01224 325345

Saturday, July 29, R M Sports Club, Newark Road, LINCOLN
Professor Basant Puri speaks to Lincolnshire ME Self-Help Group, 2pm.
Tel: 01522 871295

October 9-13, Carberry Tower, Musselburgh, near EDINBURGH
Five day caring break with people with ME. For details, phone 0131 665 3135 or email: mail@carberrytower.org

To include your event on this blog and in future issues of our ME Essential quarterly magazine, please email us by clicking here

ME "People's Day", central London, 10 May 2007

For the second year running, the annual "ME People's Day Event" in central London during ME Awareness Week is being organised by Di Newman, of the Peterborough ME and CFS Sef-Help Group.

It will be held on Thursday, 10 May 2007, starting with a demonstration in Whitehall opposite the entrance to Downing Street at 11am. A pre-arranged presentation of ME-related material to the Prime Minister will take place at 12 noon, followed by a presentation at the Richmond House headquarters of the Department of Health.

Later in the afternoon – at 1pm – participants will form a procession to the House of Commons to lobby their MPs.

For further details, click on this link to email Di Newman

New meet-up group in Glasgow

For details about this informal and friendly group, which started in Glasgow just before Christmas, please click on the headline.

E-petition to the Prime Minister

For details, please click on the headline to this item.

New helpline details for Leeds and District ME Support Group

Leeds and District ME Support Group have changed the contact person for their helpline.

Please use these details in future:

Jackie Etherington, 1 Oak Grove, Garforth, Leeds LS29 1PP
Tel: 0113 298 2070

NB: The helpline is only available between these times:
Mon 10-12am, Wed 3-4pm, Fri 2-4pm)

Thursday, February 01, 2007

APPG on ME - minutes of last meeting (Nov 2006)

All Party Parliamentary Group on M.E.

Chair: Des Turner MP
Vice-Chairs: Andrew Stunell MP
Tony Wright MP
Secretary: Ian Gibson MP
Treasurer: David Amess MP

Minutes of the meeting of the All Party Parliamentary Group on M.E.
Held 1.30pm, Thursday 16th November 2006
Committee Room 17, House of Commons

PRESENT
Dr Des Turner MP
Dr Ian Gibson MP
Steve McCabe MP
Tony Wright MP
Betty Williams MP
Andrew Stunell MP

Koyes Ahmed, Office of Dr Des Turner MP
Louise Leighton, Office of Tony Wright MP
Adrian Ward, NICE
Dr Charles Shepherd, The ME Association
Fiona Cairns, Action for M.E.
Tony Britton, The ME Association
Heather Walker, Action for M.E.
Doris Jones, 25% Group
Barbara Robinson, Suffolk Youth Parent Support Group, East Anglia Patient Partnership (EAME)
Paul Davis, RiME
Annette Barclay, person with M.E.
Jo Dubiel, person with M.E.
Rosemary de Hussy, Youth and Carers for M.E., member of World M.E. Committee
Augustine Ryan, person with M.E.
Clive Page, father of person with M.E.

APOLOGIES
David Borrow MP, Peter Bottomley, Russell Brown MP, Janet Dean MP, David Drew MP, Andrew George MP, Mike Hancock MP, Dr Evan Harris MP, Kelvin Hopkins MP, Dr Brian Iddon MP, Peter Luff MP, Dr Richard Taylor MP, Mark Todd MP, Rudi Vis MP, Hywel Williams MP

1. WELCOME
Dr Turner welcomed everyone to the meeting, especially guest speaker, the Rt Hon John Hutton MP, Secretary of State for Work and Pensions.

2. GUEST SPEAKER

The Secretary of State thanked Dr Turner for inviting him to join the Group to discuss welfare reform, guidance and benefits, including the draft medical guidance on M.E. / CFS for DWP decision-makers adjudicating claims for Disability Living Allowance (DLA) and Carer’s Allowance.

He said that the Welfare Reform Bill which is going through Parliament will replace Incapacity Benefit (IB) with a new benefit, Employment and Support Allowance (ESA). The Department for Work and Pensions (DWP) had consulted widely on the Bill, which marks the next stage in the Government’s plans to modernise the welfare system. He said the Bill was not about trying to force people to do work they were not able to do, as that would be wrong on medical and ethical grounds. Incapacity Benefit had failed: people were becoming more socially isolated and less well off. Government needed to provide help and support in getting people back into work.

Mr Hutton said that conditions like M.E. are problematic because of the fluctuating nature of the illness. Disagreement amongst the medical profession made the work of decision makers more difficult. Government recognised that too many people had to go to appeal before they received the benefits to which they were entitled. The Government aimed to cut down the number of appeals by improving decision making.

Mr Hutton said that, however much consultation took place, where medical opinion differed, it would be impossible to achieve consensus and there would be ‘hot spots’ of disagreement. Under these circumstances, the DWP’s job was to ensure a fair and transparent process.

With regards to Disability Living Allowance, the DWP would not be in a position to issue guidance until 2007. There was still the opportunity for people to be involved in the process. The next draft would be available soon.

Dr Turner noted that the Secretary of State rightly wanted to achieve high standards of professionalism amongst DWP staff and commented that high standards were also required in terms of medical input.

Mr Hutton replied by saying that the process of assessing people is done through Atos Origin. The DWP is working with Atos Origin to make sure they fulfill their contractual obligations.

Andrew Stunell made the point that there was a risk of ‘payment by inverse results’ ie. the fewer the people who were paid state benefits, the more successful the assessors and the medical guidance on M.E. might be seen to be.

Mr Hutton rejected this saying that it is a myth that there is a conspiracy to stop people getting benefits. The Government has given vulnerable people a statutory right to benefits and it is the DWP’s job to give benefits to those who are entitled to them. Consulting on the guidance is a way to improve the decision making process.

Charles Shepherd said that the drafting of guidance for DLA decision makers had taken 18 months so far and consultation had reached an impasse at version 8. There was a fundamental problem in that those drafting the guidance were receiving advice from a neurologist who did not believe in the biological nature of the illness.

Mr Hutton said that Ministers make decisions based on medical advice given, which is difficult when there is dispute among the medical profession. He had not realised that there had been so many drafts of the guidance.

Dr Turner asked Mr Hutton if the DWP had taken account of the Chief Medical Officer’s Report. Mr Hutton said ‘we’re trying.’

Barbara Robinson made a number of points, citing examples of good practice in guidance, asking how people who may be too ill too express themselves can be properly assessed, saying assessors are not adequately trained to assess people with M.E and pointing out that local GPs should get more interested and involved in M.E. cases, make more home visits and be asked to provide more evidence for the assessment process.

Mr Hutton did not dispute that better medical assessments were required and said that the DWP would listen to any sensible suggestion which helps to achieve that. He agreed that there should be more home visits for the severely affected if people wanted them.

Annette Barclay asked if Atos Origin were subject to any contractual penalties. Mr Hutton said he would write to Dr Turner, as Chair of the APPG, with details.

Mr Hutton said that it was right and proper for the DWP to assess a person’s ability to work even if they have a disability and wrong to leave a person with benefits but without adequate help and support. He invited anyone with specific concerns about DWP assessments to raise them in writing through Dr Turner as Chair of the APPG and that he as Secretary of State would respond.

Doris Jones voiced concerns that the psychiatric bias towards M.E. / CFS was already apparent in Occupational guidance recently published by NHS Plus and in the draft NICE guideline.

Mr Hutton was unable to comment on guidelines not drafted by his Department but presumed the Department of Health, like the DWP, had acted on expert advice received. He said he would raise the issue with the Secretary of State for Health.

Dr Turner thanked Mr Hutton for his attendance.

The Secretary of State left the meeting at 2.10pm

3. Group business

a. Minutes of last meeting

Doris Jones had submitted a written request for a change under 3.iii.e., as, in her experience and contrary to what was stated, DSS/DWP assessment was better 16 years ago than it is today. Clive Page asked that the minute also be changed as it implied that he and Doris Jones were both parents of the son and daughter noted, rather than members of separate families.

b. Election of Office Bearers

A question had been raised about the quoracy of the Annual General Meeting on 20 July 2006. Accordingly, the business of the Annual General Meeting was revisited and the following Office Bearers were elected:

Dr Des Turner MP (Chair), Anthony Wright MP (Vice-Chair), Andrew Stunell (Vice-Chair), David Amess (Treasurer), Dr Ian Gibson (Secretary).

The Chair took the opportunity to ask Ian Gibson for an update on the Inquiry into the progress of scientific research into M.E. since the Chief Medical Officer’s report. Dr Gibson said that the Inquiry’s report would be published very shortly, and would be submitted to NICE in time to meet its deadline for the close of the close of their consultation on ME/CFS Guidelines. He said that members of the Inquiry Group were as frustrated as many people with M.E. were by the lack of research and that the research undertaken in the UK to date was very one-sided. The Chair welcomed his comments and looked forward to the publication of the report.

c. APPG definition of M.E. and Code of Conduct

The Chair circulated a draft code of practice for the APPG (attached), which stated that: “The APPG and the Secretariat (Action for M.E. and the M.E. Association) accept the WHO Classification of M.E. as a neurological condition and welcome the recognition by the Department of Health of M.E. as a long term neurological condition. The APPG strives to support the improvement of health, social care, education and employment opportunities for people affected by M.E. The meetings of the APPG are held in public and it is expected that attendees will adhere to the principles of best practice in meetings” (which were listed).

Comments were invited.

4. Draft NICE guideline

The Chair asked for views on the draft guideline on the diagnosis and management of M.E. / CFS, produced by the National Institute for Health and Clinical Excellence (NICE). He felt the documents were extremely problematical, and ran to so many pages that they probably would not be read by the medical profession any way.

Dr Gibson agreed, saying few people would have the patience to read the guidance. He said they would be taken back to be rewritten.

Paul Davis said that the NICE guidelines ignore the WHO classification of M.E., and that that there were problems with terminology which made the guideline skewed towards vague chronic fatigue conditions and irrelevant to the assessment, diagnosis and treatment of people with M.E.

Charles Shepherd complained that NICE had paid lip-service only to the consultation process. Strongly expressed views from experienced clinicians had been airbrushed out.
NICE proposed Cognitive Behaviour Therapy and Graded Exercise Therapy as treatments of first choice without taking the economics into account: where were the CBT therapists who could treat an estimated 180,000-200,000 patients who might benefit from it? The cost of each course of CBT had been estimated at £1,000. If the recommendation was pursued that could result in the NHS being burdened with additional expenditure of £200m a year.

Dr Turner said there was one safety valve – the guideline would not be mandatory. He suggested that, as people felt so strongly on the issue, NICE should be invited to address the next meeting.

Adrian Ward, from NICE, said he was attending only in the capacity of an observer but he would make sure the views of the APPG were passed on to colleagues. He said that NICE were planning to publish the guideline in April.

Paul Davis said the APPG and the ME charities, ever since the Chief Medical Officer’s Report in 2002, had been sidetracked by issues around the treatment of ME. What RIME’s supporters wanted was for the focus to be entirely on research issues.

5. Any Other Business

The Chair said he had received a request from Di Newman, from Peterborough, who was not at the meeting, that discussion be held on the Mental Health Bill now in Parliament. It was agreed to put the item on agenda for the next meeting.

6. Next Meeting

At the Chair’s suggestion, members agreed that Sir Michael Rawlins, Chairman of the National Institute for Health and Clinical Excellence, be invited to address the next meeting about our concerns about the proposed NICE clinical guideline for CFS/ME.
He hoped a convenient date could be found early to mid-February.

The meeting closed at 2.41pm

Appendix attached…

APPENDIX

DRAFT

CODE OF PRACTICE FOR THE
ALL PARTY PARLIAMENTARY GROUP ON M.E.

1. The APPG and the Secretariat (Action for M.E. and the M.E. Association) accepts the WHO Classification of M.E. as a neurological condition and welcomes the recognition by the Department of Health of M.E. as a long term neurological condition.

2. The APPG strives to support the improvement of health, social care, education and employment opportunities for people affected by M.E.

3. The meetings of the APPG are held in public and it is expected that attendees will adhere to the principles of best practice in meetings:

• Attendees will abide by the APPG Governance Procedures and Practices

This means that the attendees will honour the policies set up by the APPG to govern its own activities, including meeting protocols, committee rules etc. It is anticipated that attendees will follow basic rules of personal courtesy, attendance and being prepared. The APPG and the Secretariat recognise the connection between the behaviour of individuals in meetings and the ability of the APPG to address their business effectively. Attendees will be expected to participate so that APPG business progresses smoothly and efficiently.

• Participants will give apologies ahead of time to the Chair if unable to attend meetings.

• The Secretariat will ensure that information is distributed prior to meetings, allowing participants time to read and digest important information ahead of a discussion.

• Attendees will honour the authority of the Chair and respect his/her role as the meeting leader. When problems arise with meetings they should be dealt with as procedural issues rather than a personal criticism of the Chair and other officers.

• Participants will engage in debate according to procedures, maintaining a respectful attitude towards the opinions of others whilst making their own point.

• Attendees must express their views clearly when it is their turn to speak and then allow others to express their opinions in turn.

• Attendees must listen respectively to other meeting participants, to the Chair and to other speakers. They must not attempt to silence minority opinions, nor should they talk over others.

• Attendees must not use their mobile phones in meetings or adopt any other bullying tactics.

• Attendees are invited to offer suggestions to the Secretariat or the Chair on how best to enhance the role and function of the APPG.

These guidelines are produced as a method of efficiency. If an individual attendee does not comply with the code the Chair may institute a warning system. The APPG anticipates that debate should be lively but controlled and every effort will be made to hear a wide range of different opinions and elicit the opinions of those who may be inclined to be silent.

NICE chairman to attend next APPG on ME

Sir Michael Rawlins, Chairman, National Institute for Health and Clinical Excellence, will appear before the next All-Party Parliamentary Group on M.E.

Thursday, 22 February 2006, 1.30pm - 2.30pm
Committee Room 17, House of Commons

The clinical practice guideline being developed by NICE for CFS/M.E. is due to be published in August. It will be the first time in four years that the NHS has drawn up guidance on the assessment, diagnosis and treatment of the illness which affects up to 240,000 adults and children in the UK.

The draft guideline was vigorously condemned by M.E. charities and patient groups after it was published in September.

A number of concerns were voiced at the last APPG, the minutes of which are now available.

Please do your best to attend this meeting.
free stats